z-logo
open-access-imgOpen Access
Autoantibodies to the collagenous region of C1q occur in three strains of lupus‐prone mice
Author(s) -
HOGARTH M. B.,
NORSWORTHY P. J.,
ALLEN P. J.,
TRINDER P. K. E.,
LOOS M.,
MORLEY B. J.,
WALPORT M. J.,
DAVIES K. A.
Publication year - 1996
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1046/j.1365-2249.1996.19725.x
Subject(s) - autoantibody , antibody , systemic lupus erythematosus , immunology , medicine , complement c1q , pathophysiology , autoimmunity , endocrinology , complement system , disease
We have developed an ELISA to measure murine autoantibodies to the collagenous region (CLR) of C1q, using the whole human C1q molecule as the solid‐phase ligand, in the presence of 1  m NaCl. The assay was validated by testing positive sera from 20 mice using purified mouse C1q, and from 10 mice using purified human C1q‐CLR, as the solid‐phase ligands. There were highly significant correlations between results obtained with human C1q (whole molecule) and: (i) mouse C1q ( r Sp  = 0.73, P  < 0.001), and (ii) human C1q‐CLR alone ( r Sp  = 0.86, P  = 0.001). Antibodies to C1q were measured in 53 MRL/ lpr , 17 BXSB and 25 NZB/W lupus‐prone mice. Median (range) anti‐C1q (CLR) antibody levels in MRL/ lpr, BXSB, and NZB/W autoimmune mice aged 3 months were 22 (16–66), 21 (17–39) and 19 (15–27) EU, respectively. The median anti‐C1q antibody level in MRL/ lpr mice aged 5 months was 76 (35–142) EU, significantly higher than that at 3 months ( U  = 558, P  < 0.0005). Median anti‐C1q antibody level in NZB/W mice at 8 months was 37 (13–74) EU and in BXSB mice at 11 months was 62 (31–231) EU, significantly higher than corresponding values at 3 months ( U  = 326, and U  = 4, P  < 0.001, respectively). This is the first demonstration of anti‐C1q (CLR) antibodies in NZB/W and BXSB mice. The pathologic significance and the potential utility of these antibodies for monitoring disease in lupus‐prone mice are under evaluation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here